EntreMed (ENMD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Bartlett who wrote (1354)	11/6/1998 10:08:00 AM
From: scaram(o)uche	Read Replies (1) of 2135

Andreas et al.: Sorry to pop in with this on "GERN day", but...... Please excuse me if these issues have been discussed at length. I have to get the kids off to school, and I don't have time to look through recent posts to the thread. Please accept my apology for asking....... A friend of mine says that he says that Folkman (ENMD) will have two abstracts at AHP that deal with endostatin/TNP 470 and the inhibition of neovascularization. #2391 deals with an animal model for restinosis/coronary artery plaque. #2394 deals with blocking the growth of adipose tissue and the normalization of serum glucose. Given the current climate, is this going to lead to another pop? Have these abstracts been discussed here? Again, very, very sorry for not taking time to review posts. Got the info and need feedback, but..... coming up right now........ breakfasts, pack lunches, mad rush to the car. Thanks, Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next